Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...
AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has ...
LX2020 generally well tolerated across ten participants with no clinically significant complement activation LX2020 transduction, transcription, ...
Holding a talking stick invites bodily stabilization and an inner rhythm conducive to reflective expression. Materiality thus ...
KRAFTON Indiaand Royal Enfieldtoday announced a landmark partnership that bridges two of India’s most influential cultural ...
Newspoint on MSN
KRAFTON, Royal Enfield team up to bring ridable bike inside game
KRAFTON India and Royal Enfieldtoday announced a landmark partnership that bridges two of India’s most influential cultural ...
SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, today announced that the first patient has been dosed in the ...
AI agents can kill busywork fast, but the real win isn’t speed — it’s resilience, smart oversight and knowing when a bot ...
Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to be generally well ...
Discover how to test for multi-user vulnerabilities. Four real-world examples of tenant isolation, consolidated testing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback